Question 1

How many shares of ACHN does UBS Group AG own?

Accepted Answer

UBS Group AG previously held 0 shares of ACHN (ACHILLION PHARMACEUTICALS IN) before exiting the position in 2020-Q1.

Question 2

What is UBS Group AG's ACHN position worth?

Accepted Answer

UBS Group AG's ACHN position was last reported at $0 in 2020-Q1 before the exit.

Question 3

Is UBS Group AG buying or selling ACHN?

Accepted Answer

In 2020-Q1, UBS Group AG exited their ACHN position entirely (-100.0% change in shares).

Question 4

When did UBS Group AG first buy ACHN?

Accepted Answer

Based on available 13F filings, UBS Group AG first reported a position in ACHN in 2019-Q1. They have held the position across 5 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2020-Q1 Latest	Exited	0	-100.0%	$0	0.0%	—	0
2019-Q4	Decreased	3.9M	-34.8%	$23.3M	0.0%	—	0
2019-Q3	Increased	5.9M	+6.4%	$21.4M	0.0%	—	30
2019-Q2	Increased	5.6M	+48.6%	$14.9M	0.0%	—	39
2019-Q1	New	3.8M	-	$11.1M	0.0%	—	38

ACHN5 quarters

ACHN
5 quarters